Literature DB >> 21701235

Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents.

Jie-Yun Song1, Hai-Jun Wang, Jun Ma, Zhi-Yuan Xu, Anke Hinney, Johannes Hebebrand, Yan Wang.   

Abstract

AIMS: We aimed to identify whether the risk G-allele was associated with fasting glucose level and other pre-diabetic and obesity-related phenotypes in Chinese children and adolescents.
METHODS: The rs10830963 polymorphism in MTNR1B was genotyped in 2,030 Chinese children and adolescents of two independent studies. Association with fasting glucose levels and risk of impaired fasting glucose (IFG) were initially tested. Subsequently we analyzed the association with fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR) and for beta cell function (HOMA-B), the quantitative insulin sensitivity check index (QUICK) and obesity-related phenotypes (BMI standard deviation score, waist circumference etc.).
RESULTS: The G-allele of rs10830963 was associated with increased fasting glucose level in Chinese children and adolescents (increase of 0.072 mmol/l per G-allele, 95% CI 0.034-0.111, p = 2.46 × 10(-4)). The G-allele was also associated with an increased risk of IFG (OR = 1.21, 95% CI 1.00-1.46, nominal p = 0.048). We found the glucose-raising G-allele was nominally associated with reduced HOMA-B. No association to other pre-diabetic or obesity-related phenotypes was detected.
CONCLUSIONS: The rs10830963 polymorphism in MTNR1B was associated with increased fasting glucose and risk of IFG in Chinese children and adolescents. The effect may result from reduced pancreatic beta cell function, but the mechanism awaits further studies.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701235      PMCID: PMC6444495          DOI: 10.1159/000329306

Source DB:  PubMed          Journal:  Obes Facts        ISSN: 1662-4025            Impact factor:   3.942


  25 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 2.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

3.  Report on childhood obesity in China (1)--body mass index reference for screening overweight and obesity in Chinese school-age children.

Authors:  Cheng-Ye Ji
Journal:  Biomed Environ Sci       Date:  2005-12       Impact factor: 3.118

4.  Normal fasting plasma glucose levels and type 2 diabetes in young men.

Authors:  Amir Tirosh; Iris Shai; Dorit Tekes-Manova; Eran Israeli; David Pereg; Tzippora Shochat; Ilan Kochba; Assaf Rudich
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

5.  An efficient procedure for genotyping single nucleotide polymorphisms.

Authors:  S Ye; S Dhillon; X Ke; A R Collins; I N Day
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

6.  Pre-teen insulin resistance predicts weight gain, impaired fasting glucose, and type 2 diabetes at age 18-19 y: a 10-y prospective study of black and white girls.

Authors:  John A Morrison; Charles J Glueck; Paul S Horn; George B Schreiber; Ping Wang
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

7.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.

Authors:  Valeriya Lyssenko; Cecilia L F Nagorny; Michael R Erdos; Nils Wierup; Anna Jonsson; Peter Spégel; Marco Bugliani; Richa Saxena; Malin Fex; Nicolo Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Peter Nilsson; Johanna Kuusisto; Jaakko Tuomilehto; Michael Boehnke; David Altshuler; Frank Sundler; Johan G Eriksson; Anne U Jackson; Markku Laakso; Piero Marchetti; Richard M Watanabe; Hindrik Mulder; Leif Groop
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

8.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Authors:  Nabila Bouatia-Naji; Amélie Bonnefond; Christine Cavalcanti-Proença; Thomas Sparsø; Johan Holmkvist; Marion Marchand; Jérôme Delplanque; Stéphane Lobbens; Ghislain Rocheleau; Emmanuelle Durand; Franck De Graeve; Jean-Claude Chèvre; Knut Borch-Johnsen; Anna-Liisa Hartikainen; Aimo Ruokonen; Jean Tichet; Michel Marre; Jacques Weill; Barbara Heude; Maithé Tauber; Katleen Lemaire; Frans Schuit; Paul Elliott; Torben Jørgensen; Guillaume Charpentier; Samy Hadjadj; Stéphane Cauchi; Martine Vaxillaire; Robert Sladek; Sophie Visvikis-Siest; Beverley Balkau; Claire Lévy-Marchal; François Pattou; David Meyre; Alexandra I F Blakemore; Marjo-Riita Jarvelin; Andrew J Walley; Torben Hansen; Christian Dina; Oluf Pedersen; Philippe Froguel
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

Review 9.  Impaired glucose regulation and type 2 diabetes in children and adolescents.

Authors:  Kerstin Kempf; Wolfgang Rathmann; Christian Herder
Journal:  Diabetes Metab Res Rev       Date:  2008-09       Impact factor: 4.876

10.  Variants in MTNR1B influence fasting glucose levels.

Authors:  Inga Prokopenko; Claudia Langenberg; Jose C Florez; Richa Saxena; Nicole Soranzo; Gudmar Thorleifsson; Ruth J F Loos; Alisa K Manning; Anne U Jackson; Yurii Aulchenko; Simon C Potter; Michael R Erdos; Serena Sanna; Jouke-Jan Hottenga; Eleanor Wheeler; Marika Kaakinen; Valeriya Lyssenko; Wei-Min Chen; Kourosh Ahmadi; Jacques S Beckmann; Richard N Bergman; Murielle Bochud; Lori L Bonnycastle; Thomas A Buchanan; Antonio Cao; Alessandra Cervino; Lachlan Coin; Francis S Collins; Laura Crisponi; Eco J C de Geus; Abbas Dehghan; Panos Deloukas; Alex S F Doney; Paul Elliott; Nelson Freimer; Vesela Gateva; Christian Herder; Albert Hofman; Thomas E Hughes; Sarah Hunt; Thomas Illig; Michael Inouye; Bo Isomaa; Toby Johnson; Augustine Kong; Maria Krestyaninova; Johanna Kuusisto; Markku Laakso; Noha Lim; Ulf Lindblad; Cecilia M Lindgren; Owen T McCann; Karen L Mohlke; Andrew D Morris; Silvia Naitza; Marco Orrù; Colin N A Palmer; Anneli Pouta; Joshua Randall; Wolfgang Rathmann; Jouko Saramies; Paul Scheet; Laura J Scott; Angelo Scuteri; Stephen Sharp; Eric Sijbrands; Jan H Smit; Kijoung Song; Valgerdur Steinthorsdottir; Heather M Stringham; Tiinamaija Tuomi; Jaakko Tuomilehto; André G Uitterlinden; Benjamin F Voight; Dawn Waterworth; H-Erich Wichmann; Gonneke Willemsen; Jacqueline C M Witteman; Xin Yuan; Jing Hua Zhao; Eleftheria Zeggini; David Schlessinger; Manjinder Sandhu; Dorret I Boomsma; Manuela Uda; Tim D Spector; Brenda Wjh Penninx; David Altshuler; Peter Vollenweider; Marjo Riitta Jarvelin; Edward Lakatta; Gerard Waeber; Caroline S Fox; Leena Peltonen; Leif C Groop; Vincent Mooser; L Adrienne Cupples; Unnur Thorsteinsdottir; Michael Boehnke; Inês Barroso; Cornelia Van Duijn; Josée Dupuis; Richard M Watanabe; Kari Stefansson; Mark I McCarthy; Nicholas J Wareham; James B Meigs; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

View more
  8 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

2.  Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA).

Authors:  Laura J Rasmussen-Torvik; Xiuqing Guo; Donald W Bowden; Alain G Bertoni; Michele M Sale; Jie Yao; David A Bluemke; Mark O Goodarzi; Y Ida Chen; Dhananjay Vaidya; Leslie J Raffel; George J Papanicolaou; James B Meigs; James S Pankow
Journal:  Genet Epidemiol       Date:  2012-04-16       Impact factor: 2.135

3.  Genetic variation in MTNR1B is associated with gestational diabetes mellitus and contributes only to the absolute level of beta cell compensation in Mexican Americans.

Authors:  Jie Ren; Anny H Xiang; Enrique Trigo; Miwa Takayanagi; Elizabeth Beale; Jean M Lawrence; Jaana Hartiala; Joyce M Richey; Hooman Allayee; Thomas A Buchanan; Richard M Watanabe
Journal:  Diabetologia       Date:  2014-04-13       Impact factor: 10.122

Review 4.  Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.

Authors:  Stefano Comai; Gabriella Gobbi
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

Review 5.  Melatonin in type 2 diabetes mellitus and obesity.

Authors:  Angeliki Karamitri; Ralf Jockers
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

Review 6.  Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease.

Authors:  Georgi Nikolaev; Ralitsa Robeva; Rossitza Konakchieva
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

7.  Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis.

Authors:  Qing Xia; Zi-Xian Chen; Yi-Chao Wang; Yu-Shui Ma; Feng Zhang; Wu Che; Da Fu; Xiao-Feng Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Association of melatonin receptor 1 B gene (rs10830963 and rs9192552) polymorphısm with adolescent obesity and related comorbidities in Turkey.

Authors:  Nilgün Çöl; Muradiye Nacak; Mustafa Araz
Journal:  J Int Med Res       Date:  2018-05-04       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.